Overexpression of PRDM16 in the presence and absence of the RUNX1/PRDM16 fusion gene in myeloid leukemias
- 9 August 2006
- journal article
- letter
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 45 (11) , 1072-1076
- https://doi.org/10.1002/gcc.20370
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AMLLeukemia, 2006
- Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cellsBlood, 2005
- Novel RUNX1‐PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22)Genes, Chromosomes and Cancer, 2005
- Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBPOncogene, 2005
- Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cellsOncogene, 2004
- A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF–induced myeloid differentiationBlood, 2003
- Low expression of MDS1-EVI1–like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemiaExperimental Hematology, 2003
- Genomic imbalances in CML blast crisis: 8q24.12–q24.13 Segment identified as a common region of over‐representationGenes, Chromosomes and Cancer, 2003
- Oncogenic interaction between BCR-ABL andNUP98-HOXA9 demonstrated by the use of an in vitro purging culture systemBlood, 2002
- Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemiaOncogene, 2001